Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T0PU
|
|||
| Former ID |
DIB016656
|
|||
| Drug Name |
CME-548
|
|||
| Synonyms |
Humanized OBA1-H8 antibody, Oxford BioMedica/Pfizer; Humanized OBA1-H8 antibody, Oxford BioMedica/Wyeth; Humanized OBA1-H8 antibody, Oxford BioMedica/Wyeth-Ayerst; Humanized OBA1-H8-calicheamicin conjugate, Oxford BioMedica/Pfizer; Humanized OBA1-H8-calicheamicin conjugate, Oxford BioMedica/Wyeth; Humanized OBA1-H8-calicheamicin conjugate, Oxford BioMedica/Wyeth-Ayerst; 5T4 antibody-targeted cancer therapy, Oxford BioMedica/Pfizer; 5T4 antibody-targeted cancer therapy, Oxford BioMedica/Wyeth
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Oxford BioMedica plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.